NCT02324738View on ClinicalTrials.gov

Pharmacokinetic and Pharmacodynamic Study of Mefloquine and Dihydroartemisinin-Piperaquine in Healthy Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Healthy
Interventions
DRUG

Mefloquine and Dihydroartemisinin-piperaquine

2 tablets of mefloquine and 3 tablets of dihydroartemisinin-piperaquine single dose

OTHER

Wash-out period

DRUG

Mefloquine

2 tablets of Mefloquine single dose

Trial Locations (1)

10400

Faculty of Tropical Medicine, Bangkok

All Listed Sponsors
lead

University of Oxford

OTHER

NCT02324738 - Pharmacokinetic and Pharmacodynamic Study of Mefloquine and Dihydroartemisinin-Piperaquine in Healthy Subjects | Biotech Hunter | Biotech Hunter